Exact Mass: 369.1688

Exact Mass Matches: 369.1688

Found 37 metabolites which its exact mass value is equals to given mass value 369.1688, within given mass tolerance error 0.001 dalton. Try search metabolite list with more accurate mass tolerance error 0.0002 dalton.

Epanolol

N-(2-{[3-(2-cyanophenoxy)-2-hydroxypropyl]amino}ethyl)-2-(4-hydroxyphenyl)acetamide

C20H23N3O4 (369.1688)

C - Cardiovascular system > C07 - Beta blocking agents > C07A - Beta blocking agents > C07AB - Beta blocking agents, selective C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D013566 - Sympathomimetics D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents Same as: D06646

(3'as,6'r,6'ar)-3'a-hydroxy-2'-imino-6'a-methoxy-6'-(4-methoxyphenyl)-3'-methyl-4',6'-dihydro-1'h-spiro[cyclohexane-1,5'-cyclopenta[d]imidazole]-2,5-dien-4-one

C20H23N3O4 (369.1688)

(5r)-5-[(4-hydroxyphenyl)methyl]-2-imino-5-[(s)-methoxy(4-methoxyphenyl)methyl]-3-methylimidazolidin-4-one

C20H23N3O4 (369.1688)

4-hydroxy-n-[(3s,5r)-2-hydroxy-3-[(4-hydroxyphenyl)methyl]-3,4,5,6,7,8-hexahydro-1,4-diazocin-5-yl]benzamide

C20H23N3O4 (369.1688)

2,15-dihydroxy-11-methoxy-14-methyl-9-(2-methylbut-3-en-2-yl)-2,13,16-triazatetracyclo[7.7.0.0¹,¹³.0³,⁸]hexadeca-3,5,7,10,15-pentaen-12-one

C20H23N3O4 (369.1688)

(1s,9r,14s)-2,15-dihydroxy-11-methoxy-14-methyl-9-(2-methylbut-3-en-2-yl)-2,13,16-triazatetracyclo[7.7.0.0¹,¹³.0³,⁸]hexadeca-3,5,7,10,15-pentaen-12-one

C20H23N3O4 (369.1688)

Exact Mass: 369.1688

Exact Mass Matches: 369.1688

Epanolol

SCHEMBL20693006

(+)-Calcaridine A

(?)-Spirocalcaridine B

5-{[2-imino-4-(4-methoxybenzyl)-1-methyl-1,2-dihydro-1H-imidazol-5-yl]methyl}-2-methoxy-1,3-benzenediol|naamine C

(-)-spiroleucettadine

turtschamide

NSC89645

Gly Phe Phe

Phe Gly Phe

Phe Phe Gly

ETHYL 6-AMINO-5-CYANO-2-METHYL-4-(4-MORPHOLINOPHENYL)-4H-PYRAN-3-CARBOXYLATE

6,7-bis(2-methoxyethoxy)-N-phenylquinazolin-4-amine

Ac-Phe-Tyr-NH2

Glycylphenylalanylphenylalanine

L-Phenylalanine, L-phenylalanylglycyl-

Phenylalanyl-phenylalanyl-glycine

Epanolol

2-[(2-acetamido-1-oxoethyl)amino]-N-(4-methoxyphenyl)-2-(4-methylphenyl)acetamide

N-[4-({2-[(2,5-dimethylphenoxy)acetyl]hydrazino}carbonyl)phenyl]propanamide

3,4,5-trimethoxy-N-[2-(1-methyl-2-benzimidazolyl)ethyl]benzamide

3-nitro-4-(2-oxolanylmethylamino)-N-(2-phenylethyl)benzamide

N-[[(2S,3S,4S)-4-(hydroxymethyl)-1-(2-methoxy-1-oxoethyl)-3-phenyl-2-azetidinyl]methyl]-2-pyridinecarboxamide

N-[[(2R,3R,4S)-4-(hydroxymethyl)-1-(2-methoxy-1-oxoethyl)-3-phenyl-2-azetidinyl]methyl]-2-pyridinecarboxamide

N-[[(2S,3R,4S)-4-(hydroxymethyl)-1-(2-methoxy-1-oxoethyl)-3-phenyl-2-azetidinyl]methyl]-2-pyridinecarboxamide

N-[[(2R,3S,4S)-4-(hydroxymethyl)-1-(2-methoxy-1-oxoethyl)-3-phenyl-2-azetidinyl]methyl]-2-pyridinecarboxamide

N-[[(2R,3S,4R)-4-(hydroxymethyl)-1-(2-methoxy-1-oxoethyl)-3-phenyl-2-azetidinyl]methyl]-2-pyridinecarboxamide

N-[[(2R,3R,4R)-4-(hydroxymethyl)-1-(2-methoxy-1-oxoethyl)-3-phenyl-2-azetidinyl]methyl]-2-pyridinecarboxamide

Gly-Phe-Phe

Phe-Gly-Phe

Phe-Phe-Gly

5-({2-imino-1-[(4-methoxyphenyl)methyl]-3-methylimidazol-4-yl}methyl)-2-methoxybenzene-1,3-diol

(3'as,6'r,6'ar)-3'a-hydroxy-2'-imino-6'a-methoxy-6'-(4-methoxyphenyl)-3'-methyl-4',6'-dihydro-1'h-spiro[cyclohexane-1,5'-cyclopenta[d]imidazole]-2,5-dien-4-one

(5r)-5-[(4-hydroxyphenyl)methyl]-2-imino-5-[(s)-methoxy(4-methoxyphenyl)methyl]-3-methylimidazolidin-4-one

4-hydroxy-n-[(3s,5r)-2-hydroxy-3-[(4-hydroxyphenyl)methyl]-3,4,5,6,7,8-hexahydro-1,4-diazocin-5-yl]benzamide

2,15-dihydroxy-11-methoxy-14-methyl-9-(2-methylbut-3-en-2-yl)-2,13,16-triazatetracyclo[7.7.0.0¹,¹³.0³,⁸]hexadeca-3,5,7,10,15-pentaen-12-one

(1s,9r,14s)-2,15-dihydroxy-11-methoxy-14-methyl-9-(2-methylbut-3-en-2-yl)-2,13,16-triazatetracyclo[7.7.0.0¹,¹³.0³,⁸]hexadeca-3,5,7,10,15-pentaen-12-one